"Progesterone Congeners" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Steroidal compounds related to PROGESTERONE, the major mammalian progestational hormone. Progesterone congeners include important progesterone precursors in the biosynthetic pathways, metabolites, derivatives, and synthetic steroids with progestational activities.
| Descriptor ID |
D045167
|
| MeSH Number(s) |
D06.472.334.851.687
|
| Concept/Terms |
Progestational Hormones, Synthetic- Progestational Hormones, Synthetic
- Synthetic Progestational Hormones
- Progestin Analogs
- Progestogens, Synthetic
- Synthetic Progestogens
- Progestins, Synthetic
- Progestational Hormone Analogues
- Progestin Analogues
- Progestagens, Synthetic
- Synthetic Progestagens
- Progestational Hormone Analogs
- Synthetic Progestins
|
Below are MeSH descriptors whose meaning is more general than "Progesterone Congeners".
Below are MeSH descriptors whose meaning is more specific than "Progesterone Congeners".
This graph shows the total number of publications written about "Progesterone Congeners" by people in this website by year, and whether "Progesterone Congeners" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 2 | 2 |
| 2002 | 1 | 0 | 1 |
| 2005 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Progesterone Congeners" by people in Profiles.
-
Health system responses to the Women's Health Initiative findings on estrogen and progestin: organizational response. J Natl Cancer Inst Monogr. 2005; (35):113-5.
-
Changes in women's use of hormones after the Women's Health Initiative estrogen and progestin trial by race, education, and income. J Natl Cancer Inst Monogr. 2005; (35):106-12.
-
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002 Jul 17; 288(3):321-33.
-
Stroke and use of low-dose oral contraceptives in young women: a pooled analysis of two US studies. Stroke. 1998 Nov; 29(11):2277-84.
-
Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group. N Engl J Med. 1998 Feb 19; 338(8):485-92.